DISCOVER INDIA

The Emerging Hub for ENT

The Indian ENT devices market is projected to grow from $420 million in 2022 to $820 million by 2030, registering a CAGR of 9% during the forecast period of 2022-2030.

ENT - Taevas

The hearing loss market in India was valued at $220 million in 2022 and is projected to reach $350 million by 2030, registering a CAGR of 8% during the forecast period.

The tonsillitis market in India was valued at $150 million in 2022 and is projected to reach $200 million by 2030, registering a CAGR of 5% during the forecast period.

Key Growth Drivers Fuelling Market ā€‹

About 63 million people in India suffer from hearing loss. The rising prevalence of these disorders is a major driver of the ENT medical devices market.Ā 

People aged 60 and above in India is expected to increase from 103 million in 2020 to 236 million by 2050, which is expected to drive the demand for ENT medical devices.

The Indian government is increasingly focusing on preventive healthcare. This is leading to increased awareness about ENT disorders and the importance of early diagnosis and treatment. This is expected to drive the demand for ENT medical devices in India.

NAVIGATING THE REGULATORY LANDSCAPE

Step-by-Step Registration Process

Product Registration

ENT medical devices in India are regulated under the Drugs and Cosmetics Act, 1940; and would require to be duly registered in India

Appoint an Authorized Indian Agent

Foreign ENT medical device companies must appoint an Indian Authorized Agent with a wholesale license to act on their behalf.

Submit the Regulatory Dossier

A dossier under form 40 with required documents must be submitted. This includes:

  • Form 40 and TR6 Challan
  • Power of Attorney
  • ISO 13485 Certificate
  • Full Quality Assurance Certificate
  • CE Design Certificate
  • Free Sale Certificate
  • Other Regulatory Approvals
  • Plant Master File (PMF) and Device Master File (DMF)

Obtain Registration Certificate in Form 41

After document submission, the CDSCO will grant license or issue a query letter (if needed). The registration certificate is valid for 3 years

Obtain Import License in Form 10

The IAR should directly apply for import license using Form 10 in the CDSCO portal. This process would take 4 to 12 weeks.

Marketing in India

Once the process is completed the products can successfully market and sell in India. The IAR must ensure compliance with reporting changes, adverse events, recalls, to the CDSCO, if any.

Our Services

Empowering your Success in the Indian Market ā€‹

Taevas is at the forefront of this expansion, supporting businesses as they navigate and conquer new markets. Our comprehensive range of services for the life sciences include

Market access solutions
Embarking on Success with Taevas

Embarking on Success with Taevas

Taevas stands ready to serve as your custom-fit partner in India, catering to your unique business requirements.

As Your Market Entry Partner
  • As your Indian Authorized Representative (IAR), we ensure your regulatory compliance
  • We identify potential distributors for your products and facilitate initial connections
  • You will lead the further development of these distributor relationships
As Your Commercial Partner
  • Along with being your IAR, we also act as your centralized distributor in India
  • We identify and appoint local distributors in different regions of India, creating a wide and efficient distribution network
  • You can focus on your core business, while we handle the complexities of distribution
As Your Operational Partner
  • Along with being your IAR, we also initiate the building of your local presence in India
  • We put together a dedicated team who takes charge of sales partnerships and manages the nuances of business operations
  • We ā€˜Buildā€™ the infrastructure and set up processes; we ā€˜Operateā€™ the business, and when you feel ready, we ā€˜Transferā€™ the control to you